| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | NEUTRAL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.09▼ | 3.08▼ | 3.07▼ | 3.10▼ | 3.30▼ |
| MA10 | 3.08▼ | 3.06▲ | 3.01▲ | 3.23▼ | 4.02▼ |
| MA20 | 3.08▼ | 3.00▲ | 3.00▲ | 3.47▼ | 4.29▼ |
| MA50 | 3.07▲ | 3.06▲ | 3.20▼ | 4.29▼ | 4.41▼ |
| MA100 | 3.01▲ | 3.22▼ | 3.36▼ | 4.39▼ | 5.60▼ |
| MA200 | 3.01▲ | 3.40▼ | 3.78▼ | 4.26▼ | 7.10▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.017▲ | 0.028▲ | -0.020▼ | -0.163▼ |
| RSI | 47.515▼ | 55.620▲ | 49.037▼ | 34.344▼ | 37.373▼ |
| STOCH | 69.378 | 70.575 | 83.640▲ | 8.968▼ | 7.206▼ |
| WILL %R | -77.778▼ | -20.000▲ | -20.000▲ | -76.404▼ | -94.117▼ |
| CCI | -38.889 | 67.945 | 89.538 | -113.941▼ | -121.017▼ |
|
Tuesday, January 27, 2026 10:59 PM
(RTTNews) - Altimmune, Inc. (ALT), a late clinical-stage biopharmaceutical company, said it entered into an agreement with a new fundamental institutional investor for the purchase and sale of 17.05 ...
|
|
Tuesday, January 06, 2026 01:29 PM
(RTTNews) - Altimmune Inc. (ALT) announced that the U.S. FDA granted Breakthrough Therapy Designation for Pemvidutide, its balanced 1:1 glucagon/GLP-1 dual receptor agonist, for the treatment of ...
|
|
Tuesday, January 06, 2026 08:53 AM
Altimmune ALT announced that the FDA has granted Breakthrough Therapy Designation to its lead pipeline candidate, pemvidutide, a novel, investigational GLP-1/glucagon dual receptor agonist, for the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/03/26 | 2.98 | 3.12 | 2.96 | 3.08 | 3,158,288 |
| 30/03/26 | 3.03 | 3.03 | 2.87 | 2.88 | 3,072,543 |
| 27/03/26 | 3.16 | 3.19 | 3.02 | 3.02 | 2,622,585 |
| 26/03/26 | 3.26 | 3.33 | 3.19 | 3.20 | 2,158,502 |
| 25/03/26 | 3.30 | 3.385 | 3.24 | 3.31 | 4,335,786 |
| 24/03/26 | 3.37 | 3.385 | 3.23 | 3.24 | 3,274,784 |
| 23/03/26 | 3.39 | 3.53 | 3.31 | 3.44 | 3,411,051 |
| 20/03/26 | 3.43 | 3.52 | 3.31 | 3.34 | 12,489,854 |
| 19/03/26 | 3.38 | 3.51 | 3.34 | 3.42 | 2,659,600 |
| 18/03/26 | 3.50 | 3.52 | 3.36 | 3.42 | 3,468,900 |
|
|
||||
|
|
||||
|
|